Skip to main content
Newsroom
Faced with the coronavirus, the 3D Program must adapt
Read more
Epicentre and the MSF Foundation work with the Nigerian Ministry of Public Health
Read more
COVID-19: The Nigerian government sets up an information and reporting system for contaminations
Read more
End of laboratory studies for the Mini-LAB
Read more
Masks for burn victims in Haiti : MSF Foundation innovates with 3D technology
Launch of Phase 2 of the application evaluation in Amman, Jordan
Read more
Yellow fever study : expansion of patient categories
Read more
Launch of the first evaluation phase of the application in Amman (Jordan)
Read more
Deployment of the first prototype on an MSF field in Haiti
Read more
Headline
3D program is deployed in Syria
Women's Health and Physiotherapy: Fighting Cancer in Malawi
Officially launching of Antibiogo : Webinar
Yemen: Supporting Malnourished Children Through Physiotherapy
Read more
One Year of Physiotherapy in Jahun, Northern Nigeria
Read more
Alert Epidemic : An Innovation to Improve Health Surveillance in Niger
Read more
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Read more
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial
Read more
Antibiogo : Results published in Nature Communications
Read more
Antibiogo in Harvard Public Health magazine
Read more
TRT World visits 3D program teams in Gaza
Read more
Antibiogo : The project is presented in The Good AI magazine
Read more
Our social media